1. HOME
2. Research Insight
3. Clinical Trial Imaging Companies - ICON plc. (Ireland) and BioTelemetry Inc. (US) are the Leading Players

The global clinical trial imaging market is projected to reach USD 1.9 billion by 2028 from USD 1.3 billion in 2023, at a CAGR of 7.8% during the forecast period. The expansion of the clinical trial imaging market is primarily propelled by factors like heightened expenditure on research and development, the upsurge in the pharmaceutical and biotechnology sector, and the proliferation of Contract Research Organizations (CROs). However, the substantial expenses associated with implementing imaging systems and conducting clinical trials stand out as significant obstacles impeding the market's progress.

Global Leading Players:

• ICON plc. (Ireland),
• BioTelemetry Inc. (US),
• Medpace Holdings, Inc. (US),
• Biomedical Systems Corporation (US),
• IXICO plc. (UK), and many more....

These key players collaboratively plays a vital role in shaping the global future.

To know about the assumptions considered for the study download the pdf brochure

ICON plc. (Ireland):

As of 2022, ICON was at the forefront of the clinical trial imaging market, occupying a prominent position. The firm's supremacy has been upheld by its robust distribution networks spanning North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. ICON employs strategies of non-organic expansion to further enhance its predominance within this market, placing emphasis on acquisitions that complement its existing business divisions.

BioTelemetry Inc. (US):

During 2022, BioTelemetry Inc. secured the second topmost position within the clinical trial imaging market. The firm's commanding standing can be credited to its robust sales and distribution network. A substantial portion of the company's revenue is directed towards Research and Development (R&D) efforts, and it pursues non-organic strategies such as acquisitions. These advancements have effectively bolstered BioTelemetry Inc.'s position within the clinical trial imaging market.

Medpace Holdings, Inc. (US):

Medpace Holdings, Inc. accounted for the third largest share of the clinical trial imaging market in 2022. The Company conducts operations in North America, Europe, Asia, South America, Africa and Australia through wholly owned subsidiaries and representative sales offices.

Here are some of the global manufacturers:

• BioClinica (United States),
• WorldCare Clinical (United States),
• Intrinsic Imaging (United States),
• VirtualScopics, LLC (United States),
• Pharmaceutical Product Development (PPD) (United States),
• ACR Image Metrix (United States), and many more....

These global manufacturers collectively shaping the global future of the clinical trial imaging market.

• BioClinica (United States):
  • BioClinica is a leading provider of clinical trial imaging solutions, offering a comprehensive suite of services for medical imaging management, central review, and data analysis. Their imaging technologies include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), and X-ray imaging modalities.
• WorldCare Clinical (United States):
  • WorldCare Clinical offers centralized imaging services for clinical trials, utilizing advanced technologies such as medical image analysis software and cloud-based platforms. They provide expert image interpretation and analysis across multiple therapeutic areas, including oncology, neurology, and cardiology.
• Intrinsic Imaging (United States):
  • Intrinsic Imaging is a medical imaging CRO specializing in providing imaging core lab services for clinical trials. They offer expertise in medical image analysis, radiological interpretation, and regulatory-compliant imaging solutions for oncology, musculoskeletal, and gastrointestinal studies.
• VirtualScopics, LLC (United States):
  • VirtualScopics, LLC is a provider of imaging and biomarker solutions for clinical trials, offering expertise in medical image analysis, quantitative imaging biomarkers, and imaging-based efficacy assessments. They support drug development programs across various therapeutic areas, including oncology, cardiovascular, and musculoskeletal disorders.
• Pharmaceutical Product Development (PPD) (United States):
  • PPD is a global CRO that offers comprehensive clinical trial services, including imaging and biomarker solutions. They provide imaging protocol design, site support, and image analysis services using advanced imaging technologies for drug development programs.
• ACR Image Metrix (United States):
  • ACR Image Metrix is a division of the American College of Radiology (ACR) that specializes in imaging core lab services for clinical trials. They offer expertise in protocol development, image acquisition, and centralized image review for oncology, cardiovascular, and musculoskeletal studies.

Related Reports:

Clinical Trial Imaging Market by Software & Service (Operational Imaging, Trial Design), Modality (CT, MRI, X-Ray, PET, Ultrasound, ECHO), Therapeutic Area (Infectious, Oncology, CNS, CVD), End User (Pharma, Biotech, CROs) - Global Forecast to 2028

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]